790 related articles for article (PubMed ID: 29427237)
21. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China.
Huang Y; Wu Y; Yang Y; Li W; Lu J; Hu Y
Sci Rep; 2017 Nov; 7(1):16092. PubMed ID: 29170433
[TBL] [Abstract][Full Text] [Related]
23. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
24. Lp-PLA
Siddiqui MK; Kennedy G; Carr F; Doney ASF; Pearson ER; Morris AD; Johnson T; McLaughlin MM; Williams RE; Palmer CNA
Diabetologia; 2018 Jun; 61(6):1344-1353. PubMed ID: 29623345
[TBL] [Abstract][Full Text] [Related]
25. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.
Wang WY; Li J; Yang D; Xu W; Zha RP; Wang YP
Cardiovasc Res; 2010 Mar; 85(4):845-52. PubMed ID: 19910444
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.
Seyfarth J; Reinehr T; Hoyer A; Reinauer C; Bächle C; Karges B; Mayatepek E; Roden M; Hofer SE; Wiegand S; Woelfle J; Kiess W; Rosenbauer J; Holl RW; Meissner T
J Inherit Metab Dis; 2018 Jan; 41(1):73-79. PubMed ID: 29027597
[TBL] [Abstract][Full Text] [Related]
27. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A
Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L
Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128
[TBL] [Abstract][Full Text] [Related]
28. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
29. Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness.
Burchardt P; Zawada A; Kaczmarek J; Marcinkaniec J; Wysocki H; Wierusz-Wysocka B; Grzymisławski M; Rzeźniczak J; Zozulińska-Ziółkiewicz D; Naskręt D
Pol Arch Med Wewn; 2016 Aug; 126(7-8):514-20. PubMed ID: 27578220
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein-associated phospholipase A
Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
[TBL] [Abstract][Full Text] [Related]
31. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.
Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599
[TBL] [Abstract][Full Text] [Related]
32. Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients.
Rosing K; Fobker M; Kannenberg F; Gunia S; Dell'Aquila AM; Kwiecien R; Stypmann J; Nofer JR
Atherosclerosis; 2013 Sep; 230(1):164-70. PubMed ID: 23958269
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
[TBL] [Abstract][Full Text] [Related]
34. A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA
Hermans N; Van der Auwera A; Breynaert A; Verlaet A; De Bruyne T; Van Gaal L; Pieters L; Verhoeven V
Trials; 2017 Jul; 18(1):302. PubMed ID: 28673363
[TBL] [Abstract][Full Text] [Related]
35. Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
Rosenson RS
Am Heart J; 2008 Mar; 155(3):499.e9-16. PubMed ID: 18294485
[TBL] [Abstract][Full Text] [Related]
36. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.
Tzotzas T; Filippatos TD; Triantos A; Bruckert E; Tselepis AD; Kiortsis DN
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):477-82. PubMed ID: 17928209
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) bound to LDL and HDL.
Tellis CC; Tselepis AD
Curr Pharm Des; 2014; 20(40):6256-69. PubMed ID: 24953389
[TBL] [Abstract][Full Text] [Related]
38. Role of vitamin D in risk factors of patients with type 2 diabetes mellitus.
Zhang Q; Wu Y; Lu Y; Fei X
Med Clin (Barc); 2020 Mar; 154(5):151-156. PubMed ID: 31255367
[TBL] [Abstract][Full Text] [Related]
39. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
Shi Y; Zhang P; Zhang L; Osman H; Mohler ER; Macphee C; Zalewski A; Postle A; Wilensky RL
Atherosclerosis; 2007 Mar; 191(1):54-62. PubMed ID: 16765356
[TBL] [Abstract][Full Text] [Related]
40. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
